Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42216567
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →A grade · PMID 42362103
View analysis →A grade · PMID 42101908
View analysis →A grade · PMID 42248607
View analysis →A grade · PMID 42260111
View analysis →A grade · PMID 42296977
View analysis →A grade · PMID 42308229
View analysis →A grade · PMID 42032072
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 42.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 30.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 42.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 10.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 42.2/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 36.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 42.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 28.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 42.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 42.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 42.0/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 10.0; sample size: 70.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 41.8/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 41.8/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 41.7/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 26.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 41.7/100. Study design: 35.0; human relevance: 20.0; therapeutic relevance: 26.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 41.6/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 33.1; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 41.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 10.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 41.0/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 20.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 40.9/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 40.9/100. Study design: 35.0; human relevance: 20.0; therapeutic relevance: 27.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 40.6/100. Study design: 35.0; human relevance: 20.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 40.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 40.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 40.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
